Numinus Wellness Inc. (OTCQX:NUMIF) sent a patent application to the World Intellectual Property Organization (WIPO) through its subsidiary, Numinus Bioscience Inc., for a prompt production process for Psilocybe and other fungi species containing psilocybin and variant compounds.
WIPO is the 1967 self-funding UN agency established to lead the development of an effective international IP system -including services, policy, information and cooperation- that enables innovation and creativity.
